Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6 Stomach Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Hemangiosarcoma 1 Fibrolamellar hepatocellular carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 42 130-nm albumin-bound paclitaxel 26 Albumin-Bound Paclitaxel 18 Irinotecan 16 Oxaliplatin 14 Fluorouracil 14 pembrolizumab 13 Nivolumab 13 Magnetic Resonance Spectroscopy 11 Leucovorin 11 Taxes 10 Specimen Handling 9 Biopsy 9 Cisplatin 8 Capecitabine 7 folfirinox 6 Radiotherapy 6 Carboplatin 6 irinotecan sucrosofate 5 durvalumab 5 Ipilimumab 5 Cyclophosphamide 5 olaparib 4 defactinib 4 Surveys and Questionnaires 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Disulfides 4 dehydroftorafur 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pancreatic Neoplasms × balstilimab × Clear all

NCT05638698 2024-09-23

TESLA

University of Kansas Medical Center

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡